Postprandial hyperlipidemia as a coronary atherosclerosis factor in patients with metabolic syndrome; corrective potential of rosuvastatin therapy
Aim. To investigate the atherogenic role of postprandial hyperlipidemia (PPH) and endothelial dysfunction (ED) in the development of coronary angiosclerosis in patients with coronary heart disease (CHD) and metabolic syndrome (MS); to study the effectiveness of rosuvastatin in the correction of thes...
Saved in:
Main Authors: | T. V. Krovyakova, P. A. Lebedev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2176 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rosuvastatin safety and efficacy in coronary heart disease patients
by: I. V. Sergienko, et al.
Published: (2006-10-01) -
Effect of folic acid and vitamin B12 plus rosuvastatin in the treatment of coronary heart disease combined with hyperlipidemia
by: Hao Wang, et al.
Published: (2025-07-01) -
Effect of nettle, burdock, dandelion and galega water extracts on postprandial hyperglycemia and hyperlipidemia in experimental type 2 diabetes mellitus
by: O. N. Nasanova
Published: (2011-06-01) -
Postprandial hyperglycemia and cardiovascular events. Acarbose therapy in patients with coronary heart disease and impaired carbohydrate metabolism
by: N. A. Logunova, et al.
Published: (2008-10-01) -
Hyperlipidemia and atherosclerosis: experimental models
by: K. I. Davletova, et al.
Published: (2025-07-01)